Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound osseous tissue engineering stephanoporate stent material and preparation thereof

A technology of bone tissue engineering and porous scaffolds, applied in medical science, prostheses, etc., can solve the problems of tissue replacement, limited sources, fatigue, etc., and achieve the effects of low cost, convenient application, and simple manufacturing process

Inactive Publication Date: 2013-04-10
KUNMING UNIV OF SCI & TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at present, the commonly used clinical methods are still based on autologous bone transplantation, allogeneic bone transplantation and the use of metals, ceramics, polymethyl methacrylate and other alternative materials, of which the use of autologous bone or allogeneic bone accounts for more than 70%; Cause new local lesions to the patient and the source is limited. Allogeneic bone has the possibility of spreading the disease and taking it as a reflection. Alternative materials such as metal, ceramics, and polymethyl methacrylate are foreign bodies that cannot be replaced by the body's own tissues. Complications such as fatigue and fracture

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound osseous tissue engineering stephanoporate stent material and preparation thereof
  • Compound osseous tissue engineering stephanoporate stent material and preparation thereof
  • Compound osseous tissue engineering stephanoporate stent material and preparation thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1: citric acid (formic acid, acetic acid, propionic acid, lactic acid or maleic acid) is dissolved in water to form 7.25 * 10 -2 g / ml of citric acid aqueous solution, chitosan is dissolved in the above citric acid aqueous solution to form chitosan / citric acid aqueous solution, wherein chitosan / citric acid mass ratio is 1:1.2, add phosphoric acid, wherein phosphoric acid / citric acid The molar mass ratio is 4.46:1, diluted to a citric acid concentration of 1.72×10 -3 g / ml, fully stirred evenly, and set aside;

[0039] Dissolve calcium hydroxide in water to form 1.46×10 -2 g / ml calcium hydroxide aqueous solution, stir well and set aside;

[0040] The molar mass ratio of calcium hydroxide / phosphoric acid is 1:0.6 to take the above two liquids to co-precipitate to generate hydroxyapatite, wherein the chitosan / citric acid / phosphoric acid aqueous solution dropping rate is 1.167ml / min, and the calcium hydroxide aqueous solution drops The acceleration rate was 4.33...

Embodiment 2

[0041] Embodiment 2: the molecular weight is 1 * 10 5 Dalton, viscosity 3.6×10 5 The konjac glucomannan of Mpa s is dissolved in water and obtains the konjac glucomannan aqueous solution that concentration is 0.01g / ml; The hydroxyapatite / chitosan composite powder in embodiment 1 is dissolved in water, obtains concentration The hydroxyapatite / chitosan composite powder suspension of 0.075g / ml; the above-mentioned konjac glucomannan aqueous solution and the hydroxyapatite / chitosan composite powder suspension with a volume ratio of 1:2 Mix, add ammonia water to adjust the pH value, wherein ammonia water [OH - ] The concentration in the mixture is 0.025%; aging at 80°C for 24 hours, removing alkali for 24 hours to obtain konjac glucomannan / hydroxyapatite / chitosan composite gel; freezing at -10°C to obtain konjac glucomannan / Hydroxyapatite / chitosan cryogel; freeze-dried at -50°C to obtain a degradable porous scaffold for konjac glucomannan / hydroxyapatite / chitosan composite bone t...

Embodiment 3

[0042] Embodiment 3: the molecular weight is 1 * 10 5 Dalton, viscosity 3.6×10 5 The konjac glucomannan of Mpa s is dissolved in water and obtains the konjac glucomannan aqueous solution that concentration is 0.01g / ml; The hydroxyapatite / chitosan composite powder in embodiment 1 is dissolved in water, obtains concentration Be the hydroxyapatite / chitosan composite powder suspension of 0.190g / ml; The above-mentioned konjac glucomannan aqueous solution and hydroxyapatite / chitosan composite powder suspension are with the volume ratio of 1: 1 Mix, add ammonia water to adjust the pH value, wherein ammonia water [OH - ] The concentration in the mixture is 0.050%; aging at 80°C for 24 hours, removing alkali for 48 hours to obtain konjac glucomannan / hydroxyapatite / chitosan composite gel; freezing at -20°C to obtain konjac glucomannan / Hydroxyapatite / chitosan cryogel; freeze-dried at -50°C to obtain a degradable porous scaffold for konjac glucomannan / hydroxyapatite / chitosan composite ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
pore sizeaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a porous support material in the tissue engineering of konjac glucan-mannan / hydroxyapatite / chitosan combined bone, and a preparation thereof, pertaining to the technical field of bioengineering materials. Degradable biomaterials with good biocompatibility, such as konjac glucan-mannan, hydroxyapatite and chitosan, are adopted as basic raw materials and respectively prepared into konjac glucan-mannan solution and hydroxyapatite / chitosan composite powder suspension which are then mixed to prepare mixture gel. After aging, alkali elimination, freeze-drying of the mixturegel, the degradable porous support with regenerated and reparative konjac glucan-mannan / hydroxyapatite / chitosan combined bone tissues. Not only does the support material have simple preparation technology and low cost, but also the prepared degradable porous support has good compatibility with trauma parts. Cell tests and animal tests show that the support can be universally used in vivo (bone defect diseased region, etc.) and is multifunctional and antibacterial composite material with adjustable degradation rate in vivo and can promote and induce the repair of the bone defect.

Description

technical field [0001] The invention relates to a bioengineering material and a preparation method thereof, in particular to a degradable porous scaffold for bone tissue repair and regeneration, which belongs to the technical field of bioengineering materials. Background technique [0002] In the past half century, bone tissue repair has been proposed despite various repair approaches, including the use of tissue engineering products [Langer R, et al. Science, 1993; 260:920-926], gene therapy [Mulligan RC, et al .Science, 1993; 260-932] et al. However, at present, the commonly used clinical methods are still based on autologous bone transplantation, allogeneic bone transplantation and the use of metals, ceramics, polymethyl methacrylate and other alternative materials, of which the use of autologous bone or allogeneic bone accounts for more than 70%; Cause new local lesions to the patient and the source is limited. Allogeneic bone has the possibility of spreading the diseas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61L27/40A61L27/56
Inventor 陈庆华赵昆渝洪东峰
Owner KUNMING UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products